The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stenting

Yonsei Medical Journal

Volumn 54, Issue 2, 2013, Pages 288-294

  Song, Tae Jin ^a   Suh, Sang Hyun ^a,b   Min, Pil Ki ^a,b   Kim, Dong Joon ^a   Kim, Byung Moon ^a   Heo, Ji Hoe ^a   Kim, Young Dae ^a   Lee, Kyung Yul ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Aspirin resistance; Carotid artery stent; Cerebral infarction; Clopidogrel resistance

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

AGED; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY STENTING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

AGED; ASPIRIN; BRAIN ISCHEMIA; CAROTID ARTERIES; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; STENTS;

EID: 84873257536     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.2.288     Document Type: Article

References (30)

1. Poppert H, Wolf O, Resch M, Theiss W, Schmidt-Thieme T, Graefin von Einsiedel H, et al. Differences in number, size and location of intracranial microembolic lesions after surgical versus endovascular treatment without protection device of carotid artery stenosis. J Neurol 2004;251:1198-203.
2. Hammer FD, Lacroix V, Duprez T, Grandin C, Verhelst R, Peeters A, et al. Cerebral microembolization after protected carotid artery stenting in surgical high-risk patients: results of a 2-year prospective study. J Vasc Surg 2005;42:847-53.
3. European Stroke Initiative Executive Committee; EUSI Writing Committee, Olsen TS, Langhorne P, Diener HC, Hennerici M, et al. European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis 2003;16:311-37.
4. Gossetti B, Gattuso R, Irace L, Faccenna F, Venosi S, Bozzao L, et al. Embolism to the brain during carotid stenting and surgery. Acta Chir Belg 2007;107:151-4.
5. Schlüter M, Tübler T, Steffens JC, Mathey DG, Schofer J. Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coll Cardiol 2003;42:1007-13.
6. Hauth EA, Jansen C, Drescher R, Schwartz M, Forsting M, Jaeger HJ, et al. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting. AJNR Am J Neuroradiol 2005;26:2336-41.
7. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Barrera-Ramirez C, Sabaté M, et al. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting. Thromb Res 2005;115:101-8.
8. Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, et al. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. Am J Cardiol 2006;98: 1156-9.
9. Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3171-5.
10. Prabhakaran S, Wells KR, Lee VH, Flaherty CA, Lopes DK. Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 2008;29: 281-5.
11. Reavey-Cantwell JF, Fox WC, Reichwage BD, Fautheree GL, Velat GJ, Whiting JH, et al. Factors associated with aspirin resistance in patients premedicated with aspirin and clopidogrel for endovascular neurosurgery. Neurosurgery 2009;64:890-5.
12. Lee DH, Arat A, Morsi H, Shaltoni H, Harris JR, Mawad ME. Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 2008;29:1389-94.
13. Montorsi P, Galli S, Ravagnani P, Ruchin P, Lualdi A, Fabbiocchi F, et al. Randomized trial of predilation versus direct stenting for treatment of carotid artery stenosis. Int J Cardiol 2010;138:233-8.
14. Jaeger HJ, Mathias KD, Hauth E, Drescher R, Gissler HM, Hennigs S, et al. Cerebral ischemia detected with diffusion-weighted MR imaging after stent implantation in the carotid artery. AJNR Am J Neuroradiol 2002;23:200-7.
15. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol 2008;52:1128-33.
16. Mangiacapra F, Patti G, Peace A, Gatto L, Vizzi V, Ricottini E, et al. Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention. Am J Cardiol 2010;106:619-23.
17. Piñero P, González A, Martínez E, Mayol A, Rafel E, González-Marcos JR, et al. Volume and composition of emboli in neuroprotected stenting of the carotid artery. AJNR Am J Neuroradiol 2009;30:473-8.
18. Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ 2008;336:195-8.
19. Müller I, Besta F, Schulz C, Massberg S, Schönig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 2003;89:783-7.
20. Oqueli E, Hiscock M, Dick R. Clopidogrel resistance. Heart Lung Circ 2007;16 Suppl 3:S17-28.
21. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. Eur Heart J 2006;27:647-54.
22. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33.
23. McDonnell CO, Fearn SJ, Baker SR, Goodman MA, Price D, Lawrence-Brown MM. Value of diffusion-weighted MRI during carotid angioplasty and stenting. Eur J Vasc Endovasc Surg 2006; 32:46-50.
24. Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231-41.
25. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Bender J, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206-10.
26. du Mesnil de Rochemont R, Schneider S, Yan B, Lehr A, Sitzer M, Berkefeld J. Diffusion-weighted MR imaging lesions after filter-protected stenting of high-grade symptomatic carotid artery stenoses. AJNR Am J Neuroradiol 2006;27:1321-5.
27. Jaeger HJ, Mathias KD, Drescher R, Hauth E, Bockisch G, Demirel E, et al. Diffusion-weighted MR imaging after angioplasty or angioplasty plus stenting of arteries supplying the brain. AJNR Am J Neuroradiol 2001;22:1251-9.
28. Piñero P, González A, Mayol A, Martínez E, González-Marcos JR, Boza F, et al. Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study. AJNR Am J Neuroradiol 2006;27:1338-45.
29. Palombo G, Faraglia V, Stella N, Giugni E, Bozzao A, Taurino M. Late evaluation of silent cerebral ischemia detected by diffusion-weighted MR imaging after filter-protected carotid artery stenting. AJNR Am J Neuroradiol 2008;29:1340-3.
30. Lee SY, Kim WJ, Suh SH, Oh SH, Lee KY. Higher lesion detection by 3.0T MRI in patient with transient global amnesia. Yonsei Med J 2009;50:211-4.